We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The new assay is the first in a series of planned quantitative assays to support patient care following transplant surgery, the company said. Read More
Diadem’s AlzoSure Predict blood-based biomarker test for early prediction of Alzheimer's disease (AD) can accurately forecast whether individuals will develop the disease six years prior to a diagnosis, according to research reported in the Journal of Prevention of Alzheimer's Disease. Read More
The device yields a greater quantity of diagnostically relevant biopsy tissue for diagnosis of pancreatic cancer and other life-threatening GI cancers more quickly and less traumatically than existing devices, the company said. Read More